Rigas farmaceitiska fabrika AS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Rigas Farmaceitiska Fabrika AS Issues FY 2013 Net Turnover and Net Profit Guidance
Rigas Farmaceitiska Fabrika AS announced that it expects for fiscal year 2013 to increase its net turnover till EUR 2,650,000 (LVL 1,860,000) and its net profit till EUR 60,000 (LVL 40,000).
Latest Developments for Rigas farmaceitiska fabrika AS
- CAPITAL HOLDING updates on takeover bid for Rigas farmaceitiska fabrika AS - NASDAQ OMX RIGA
- Rigas Farmaceitiska Fabrika AS announces further information concerning mandatory takeover bid by Capital Holding SIA
- Capital Holding SIA announces mandatory takeover bid of Rigas Farmaceitiska Fabrika AS shares
- Capital Holding SIA increases its stake in Rigas Farmaceitiska Fabrika AS
Latest Key Developments in Pharmaceuticals
- OPKO Health submits investigational new drug application to initiate phase 2a trial for long-acting coagulation factor VIIa-CTP to treat hemophilia
- AbbVie Inc reaffirms FY 2015 EPS outlook
- Eli Lilly and Co reaffirms FY 2015 EPS outlook; lowers FY 2015 revenue outlook
- Aarti Drugs have announces bonus equity shares
- Share this
- Digg this